CDEK
← All drugs Report issue

hepalatide

Peptideexperimental

Clinical trial activity

9 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
7
Phase 3
1
Phase 4
0

Earliest trial started Oct 1, 2015 (NCT02612506)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2026

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • hepalatide

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07309380Phase 3Apr 30, 2026Jinlin University, Shanghai HEP Pharmaceatical Co., Ltd.
NCT06505928Phase 2Sep 1, 2024Shanghai HEP Pharmaceatical Co., Ltd.
NCT05827146Phase 2Oct 15, 2023Jinlin University, Shanghai HEP Pharmaceatical Co., Ltd.
NCT05244057Phase 2Aug 23, 2022Huazhong University of Science and Technology, Jiao Tong University, Shanghai HEP Pharmaceatical Co., Ltd.
NCT05133856Phase 2Dec 31, 2021Jiao Tong University, Shanghai HEP Pharmaceatical Co., Ltd.
NCT04662164Phase 1/Phase 2 (Phase 2)Dec 31, 2020Shanghai HEP Pharmaceatical Co., Ltd.
NCT04426968Phase 2Aug 31, 2020People's Liberation Army of China, Shanghai HEP Pharmaceatical Co., Ltd.
NCT03023787Phase 1Aug 1, 2016People's Liberation Army of China, Shanghai HEP Pharmaceatical Co., Ltd.
NCT02612506Phase 1Oct 1, 2015People's Liberation Army of China, Shanghai HEP Pharmaceatical Co., Ltd.
Showing 9 of 9 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Shanghai HEP Pharmaceatical Co., Ltd.For profit9932015
People's Liberation Army of ChinaGovernment3022015
Jiao Tong UniversityAcademic/Hospital2012021
Jinlin UniversityAcademic/Hospital2022023
Huazhong University of Science and TechnologyAcademic/Hospital1012022
5 organizations
Page 1 / 1